Francis Berenbaum

Sorbonne University

Francis Berenbaum is Professor of Rheumatology at Sorbonne University - Saint-Antoine Hospital, AP-HP in Paris, France. He conducts translational research at the Centre de Recherche Saint-Antoine (Inserm), focusing on the metabolic and inflammatory mechanisms of osteoarthritis and the development of innovative therapies. He is a former President of the OARSI and co-founder and Chief Medical Officer of 4Moving Biotech, which is clinically developing intra-articular GLP-1 receptor agonists for the treatment of osteoarthritis.